Home » Business » Drug companies pledge to uphold scientific standards in race for vaccine

Drug companies pledge to uphold scientific standards in race for vaccine

As we trek through month six of lockdown life, many of us are anxiously awaiting the arrival of a Covid-19 vaccine and the potential to return to some semblance of normal life. However, releasing and distributing a vaccine that has not been adequately screened poses its own host of potential safety issues.

This is why a coalition of nine drug companies from the US and Europe came together this week to pledge to uphold standards for science and safety when it comes to marketing a Covid-19 vaccine. 

The group of companies includes Johnson & Johnson, GlaxoSmithKline, Merck, Novavax, Sanofi, and BioNTech, as well as three companies already in the final stage of testing a vaccine: Pfizer, Moderna, and AstraZeneca. 

The pledge’s specifics include a commitment to “only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA.”

Many companies are facing intense pressure from governments and business leaders to make a functional vaccine available as soon as possible, but an ineffective or potentially dangerous vaccine could compound Covid-19 challenges around the world. This pledge ensures the companies will not distribute a preventative treatment that has not gone through the proper scientific and regulatory processes. 

Solution News Source



We respect your privacy and take protecting it seriously. Privacy Policy